RECORDATI rencontre des analystes financiers et la presse sp?cialis?e ? Milan

Milan, le 30 janvier 2007 – Recordati Industria Chimica e Farmaceutica S.p.A. recevra des analystes financiers et des membres de la presse spécialisée le

Jeudi 8 février 2007 à 17h00
au Palazzo Mezzanotte
Piazza degli Affari, 6 - Milan

Le but de cette rencontre est de communiquer et commenter les résultats de l'année 2006, mais également de présenter la stratégie du Groupe pour l'année 2007.

Une conference call en anglais permettra de suivre les débats. Les numéros de téléphone sont :

Italy: + 39 02 802 09 11
UK: + 44 208 7929 750
USA: + 1 866 2396 425
France: + 33 170 700 532
Germany: + 49 69 2222 2225

Recordati, established in 1926, is a European pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), dedicated to the research, development, manufacturing and marketing of pharmaceuticals, with headquarters in Milan, Italy, operations in the main European countries, and a total staff of over 2,000. A European field force of over 1,000 medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas. Recordati's current and growing coverage of the European pharmaceutical market makes it a partner of choice for new product licenses from companies which do not have European marketing organizations. Recordati is committed to the research of new drug entities within the cardiovascular and urogenital therapeutic areas in which its research team has proven scientific competence and a track record of discovery and development of original drugs, the most recent of which, lercanidipine, a latest generation calcium channel blocker for the treatment of hypertension, is the company's leading product. Consolidated revenue for 2005 was € 576.1 million, operating income was € 111.1 million and net income was € 64.5 million.

For further information:

Recordati website: www.recordati.com

Investor Relations
Marianne Tatschke
(39)0248787393
e-mail: [email protected]

Media Relations
Claudio Rossetti (Echo Comunicazione d'Impresa)
(39)02 62694736
e-mail: [email protected]

Statements contained in this release, other than historical facts, are "forward-looking statements" (as such term is defined in the Private Securities Litigation Reform Act of 1995). These statements are based on currently available information, on current best estimates, and on assumptions believed to be reasonable. This information, these estimates and assumptions may prove to be incomplete or erroneous, and involve numerous risks and uncertainties, beyond the Company's control. Hence, actual results may differ materially from those expressed or implied by such forward-looking statements.
All mentions and descriptions of Recordati products are intended solely as information on the general nature of the company's activities and are not intended to indicate the advisability of administering any product in any particular instance.

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.
VIA M. CIVITALI, 1 - 20148 MILANO, ITALY - TEL. (39) 02 48787.1 - FAX (39) 02 40073747
CORPORATE COMMUNICATIONS - TEL. (39) 02 48787.576 - FAX (39) 02 40074767